Document Detail

Results of chemoradiotherapy for stage I esophageal cancer in medically inoperable patients compared with results in operable patients.
MedLine Citation:
PMID:  22925398     Owner:  NLM     Status:  Publisher    
The purpose of the present study was to evaluate long-term results of chemoradiotherapy for clinical T1b-2N0M0 esophageal cancer and to compare outcomes for operable and inoperable patients. Patients with stage I esophageal cancer (Union for International Cancer Control [UICC] 2009), excluding patients with cT1a esophageal cancer, were studied. All patients had histologically proven squamous cell carcinoma. Operable patients received cisplatin and 5-fluorouracil with concurrent radiotherapy of 60 Gy including a 2-week break. Inoperable patients received nedaplatin and 5-fluorouracil with concurrent radiotherapy of 60-70 Gy without a pause. End-points were overall survival rate (OS), cause-specific survival rate (CSS), progression-free survival rate (PFS), and locoregional control rate (LC). Thirty-seven operable patients and 30 medically inoperable patients were enrolled. There was a significant difference in only age between the operable group and inoperable group (P = 0.04). The median observation period was 67.9 months. In all patients, 5-year OS, CSS, PFS, and LC were 77.9%, 91.5%, 66.9%, and 80.8%, respectively. Comparison of the operable group and inoperable group showed that there was a significant difference in OS (5-year, 85.5% vs. 68.7%, P = 0.04), but there was no difference in CSS, PFS, or LC. Grade 3 or more late toxicity according to Common Terminology Criteria for Adverse Events v 3.0 was found in seven patients. Even in medically inoperable patients with stage I esophageal cancer, LC of more than 80% can be achieved with chemoradiotherapy. However, OS in medically inoperable patients is significantly worse than that in operable patients.
K Jingu; H Matsushita; K Takeda; K Narazaki; H Ariga; R Umezawa; T Sugawara; G Miyata; K Onodera; K Nemoto; S Yamada
Related Documents :
24149098 - Stratification of de novo adult aml with adverse-risk karyotype: can we overcome the wo...
9477128 - High dose cytosine arabinoside is a major risk factor for the development of hepatosple...
1385638 - Pediatric leukemia/lymphoma with t(8;14)(q24;q11).
207178 - Prognostic significance of morphologic and cytochemical markers in adult acute leukemia.
7880928 - Chronic myelogenous leukemia and exposure to ionizing radiation--a retrospective study ...
11888868 - Prognostic factors after isolated limb infusion with cytotoxic agents for melanoma.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-8-23
Journal Detail:
Title:  Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus / I.S.D.E     Volume:  -     ISSN:  1442-2050     ISO Abbreviation:  Dis. Esophagus     Publication Date:  2012 Aug 
Date Detail:
Created Date:  2012-8-28     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8809160     Medline TA:  Dis Esophagus     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
© 2012 Copyright the Authors. Journal compilation © 2012, Wiley Periodicals, Inc. and the International Society for Diseases of the Esophagus.
Department of Radiation Oncology, Tohoku University School of Medicine, Sendai.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Comprehensive care of the patient with haemophilia and inhibitors undergoing surgery: practical aspe...
Next Document:  Oviductal, endometrial and embryonic gene expression patterns as molecular clues for pregnancy estab...